p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

Item
http://www.wikidata.org/entity/Q34786457
Triple negative breast cancer: looking for the missing link between biology and treatmentsTrial Watch-Immunostimulation with cytokines in cancer therapyBody mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs.Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt studyBody mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer.Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.
P2860

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

Item
http://www.wikidata.org/entity/Q34786457
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
p53 status as effect modifier ...... ents treated with trastuzumab.
@ast
p53 status as effect modifier ...... ents treated with trastuzumab.
@en
p53 status as effect modifier ...... ents treated with trastuzumab.
@nl
type
label
p53 status as effect modifier ...... ents treated with trastuzumab.
@ast
p53 status as effect modifier ...... ents treated with trastuzumab.
@en
p53 status as effect modifier ...... ents treated with trastuzumab.
@nl
prefLabel
p53 status as effect modifier ...... ents treated with trastuzumab.
@ast
p53 status as effect modifier ...... ents treated with trastuzumab.
@en
p53 status as effect modifier ...... ents treated with trastuzumab.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
p53 status as effect modifier ...... ients treated with trastuzumab
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932